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Bone marrow and kidney 
transplantation helps tolerance to 
the kidney in humans
Two brief reports demonstrate simultaneous bone marrow and 
kidney transplantation as a means to induce tolerance to the 
kidney in humans. This technique, which has been successful 
in animals, is based on the premise that continued presence of 
the organ donor’s immune cells within the recipient promotes 
and maintains immune tolerance by aﬀecting T-cell clones that 
can react to kidney alloantigens.
The ﬁrst report describes ﬁve patients with parent or sib-
ling donors mismatched for one human leukocyte antigen 
haplotype.1 Recipients received cyclophosphamide, human-
ized anti-CD2 monoclonal antibody, and thymic irradiation. 
On the basis of experience with the ﬁrst two patients, sub-
sequent recipients also received rituximab and prednisone. 
Kidney transplantation was followed by intravenous infusion 
of the donor’s bone marrow. Oral cyclosporine A was given 
postoperatively. All patients had detectable chimerism 7 days 
later, while only one patient remained chimeric 14 and 21 days 
later (Figure). Of the four who did not retain their chimer-
ism, one patient had graft failure 10 days later and underwent 
retransplantation. Of the four without graft failure, each was 
successfully withdrawn from immunosuppression at a range of 
240–422 days later. The second report, a detailed case report, 
describes six patients enrolled in a similar protocol.2 Recipi-
ents received total lymphoid irradiation, and antithymocyte 
globulin to allow engraftment of the donor hematopoietic cells. 
The ﬁrst patient had persistent mixed chimerism. The kidney 
allograft functioned normally for more than 28 months after 
discontinuation of immunosuppression. Of the ﬁve additional 
patients, the second had biopsy-conﬁrmed relapse of focal 
segmental glomerular sclerosis. The third lost his chimeric 
states by the ﬁfth month but maintained a serum creatinine 
of 1.1 mg/dl 20 months after transplantation on cyclosporine 
therapy alone. The last three patients enrolled continued only 
recently to be in chimeric states following an increase in the 
centigray units delivered during total lymphoid irradiation.
These two series represent very early evidence for the 
feasibility and safety of simultaneous bone marrow and kid-
ney transplantation from a living related donor. Although the 
word ‘early’ should clearly be emphasized, these conclusions 
suggest that the Holy Grail of immune tolerance may be within 
our reach. (1N Engl J Med 2008; 358: 353–361. 2N Engl J Med 
2008; 358: 362–368)
Lynda Szczech
Localization of Foxp3+ T cells 
within renal allografts mimics 
rejection
Kidney transplantation is the best form of treatment for end-
stage renal failure. Despite a high success rate with graft survival 
in the ﬁrst year after transplantation, acute rejection remains 
the principal cause of graft loss and contributes to chronic kid-
ney damage. Although serum creatinine is a good measurement 
of renal function, histological analysis of biopsy samples is the 
only reliable way of diagnosing rejection. Biopsy samples are 
evaluated according to the Banﬀ classiﬁcation, which states that 
Patient 1
Patient 2
Clinical course of patients with tolerance of kidney transplants.
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CD4 straining in DBA/2 kidney graft.
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inﬁltration of tubules by mononuclear cells is an indicator of 
acute rejection. However, regulatory T cells play a crucial role 
in the overall immune response and are also present within 
transplanted tissue.
In a recent study, Brown et al. hypothesized that inﬁltration of 
mononuclear cells within kidney grafts is not always associated 
with rejection, especially if a high proportion of this inﬁltrate is 
regulatory T cells. Using a life-sustaining mouse kidney trans-
plant model, they found that mononuclear-cell tubular inﬁltration 
occurred in both rejecting and tolerant grafts (Figure). However, 
tolerant kidney grafts demonstrated a higher and sustained level 
of Foxp3+ regulatory cells. Importantly, a signiﬁcant proportion 
of these cells were found within tubules. In cases in which graft 
function was normal, these cells were not harmful to the kidney 
and could be said to be mimicking, rather than causing, rejection. 
Application of conclusions drawn from animal experiments to 
clinical use should include the limitations. These data suggest that 
inﬁltration of tubules by mononuclear cells may not be an abso-
lute marker of rejection because it also occurs in tolerant kidneys, 
contrary to current opinion. Analyzing this inﬁltrate more closely 
may identify any regulatory element incorporated within it. (Am J 
Pathol 2007; 171: 1915–1922; doi:10.2353/ajpath.2007.070396)
Detlef Schlöndorﬀ
G protein-mediated signaling 
in vascular smooth muscle cells 
is required for salt-induced 
hypertension
It is well established that dietary salt intake contributes to the 
pathogenesis of hypertension, but the mechanism(s) by which 
salt increases blood pressure is unclear. Increased sodium intake 
increases extracellular ﬂuid volume and cardiac output. For unclear 
reasons, this is followed by an increased tone of resistance blood 
vessels. The result, elevated total peripheral vascular resistance, is 
a hallmark of hypertension. Recent studies have suggested that 
salt increases vascular tone via endogenous factors that promote 
increased Ca2+ entry via the Na+–Ca2+ exchanger, but many issues 
surrounding this process remain unresolved. Regulation of vas-
cular resistance under normotensive and hypertensive conditions 
involves multiple neural, humoral, and rheological stimuli that 
modulate the phosphorylation state of the myosin light chain 
(MLC). Many of these mediators act through G protein-coupled 
receptors on vascular smooth muscle cells. Receptors that mediate 
vasoconstriction couple with the G proteins Gq-G11 and G12-G13 to 
stimulate phosphorylation of MLC via the Ca2+/MLC kinase- and 
Rho/Rho kinase-mediated signaling pathways, respectively. In a 
recent study, Wirth et al. used genetically altered mouse models 
that allowed for acute abrogation of both signaling pathways by 
inducible Cre/loxP-mediated mutagenesis in smooth muscle cells. 
They found that Gq-G11-mediated signaling in smooth muscle cells 
was required for both maintenance of basal blood pressure and 
the development of salt-induced hypertension. In contrast, lack 
of G12-G13 and their major eﬀector, the leukemia-associated Rho 
guanine nucleotide exchange factor, did not alter normal blood 
pressure regulation but did block the development of salt-induced 
hypertension. These exciting results identify G12-G13–leukemia-
associated Rho guanine nucleotide exchange factor as a signaling 
pathway that could be a new target for antihypertensive therapy. 
(Nat Med 2008; 14: 64–68; doi:10.1038/nm1666)
Juan Oliver
Podocytes use Fc receptors to 
clear IgG from the glomerular 
basement membrane
The ﬁltration barrier of the glomerulus is composed of fenes-
trated endothelial cells, the glomerular basement membrane 
(GBM), and the foot processes and slit diaphragms of the podo-
cytes. These three components work together to form a size- 
and charge-selective ﬁlter that blocks the passage of cells and 
larger proteins into the urine. The exact mechanism of ﬁltration 
has been an active area of research for the past 50 years. It is 
not known, however, why the ﬁlter does not routinely clog with 
large proteins that enter the GBM. Akilesh et al. now provide 
evidence that an active transport mechanism exists to remove 
immunoglobulins that accumulate at the ﬁltration barrier. They 
found that the Fc receptor, an IgG and albumin transport recep-
tor, was expressed in podocytes and internalized IgG from the 
GBM. Mice lacking the Fc receptor accumulated IgG in the 
GBM as they aged, and tracer studies showed delayed clear-
ance of IgG from the kidneys of the Fc receptor-deﬁcient mice 
(Figure). Saturating the clearance mechanism potentiated the 
pathogenicity of nephrotoxic sera, which suggest a role for 
this pathway in disease. These studies support the idea that 
podocytes play an active role in removing proteins from the 
GBM, and that genetic or acquired impairment of the clearance 
machinery is likely a common mechanism promoting glomer-
ular diseases. (Proc Natl Acad Sci USA 2008; 105: 967–972; 
doi:10.1073/pnas.0711515105)
Detlef Schlöndorﬀ
Fc receptor-deficient mice have a reduced ability to clear IgG from the 
glomerular basement membrane.
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